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The body first encounters deleterious inhaled substances, such as allergens, industrial particles,
pollutants, and infectious agents, at the airway epithelium. When this occurs, the epithelium and
its resident inflammatory cells respond defensively by increasing production of cytokines,
mucus, and reactive oxygen and nitrogen species (ROS/RNS). As inflammation in the airway
increases, additional infiltrating cells increase the level of these products. Recent interest has
focused on ROS/RNS as potential modulators of the expression of inflammation-associated
genes important to the pathogenesis of various respiratory diseases. ROS/RNS appear to play
a variety of roles that lead to changes in expression of genes such as interleukin-6 and
intercellular adhesion molecule 1. By controlling this regulation, the reactive species can serve
as exogenous stimuli, as intercellular signaling molecules, and as modulators of the redox state
in epithelial cells. Unraveling the molecular mechanisms affected by ROS/RNS acting in these
capacities should aid in the understanding of how stimulated defense mechanisms within the
airway can lead to disease. Environ Health Perspect 106(Suppl 5):1197-1203 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-5/1 197-1203martin/abstract.html
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Introduction
The airway epithelium is the body's first
physiologic barrier to deleterious airborne
substances such as allergens, industrial par-
ticles, pollutants, and infectious agents. As
a first line of defense, these offending
substances are sequestered in the mucus
layer covering the airway, where ciliary
movement can remove them (1,2).
Resident phagocytic cells also function in
this removal process (3). Furthermore, as
the epithelial cells encounter these inhaled
substances, they respond defensively by
producing inflammatory cytokines,
increasing mucus secretion, and generating
reactive oxygen and nitrogen species
(ROS/RNS) (4).
Substances produced by the epithelial
cells after inhalation of deleterious sub-
stances can play a role in recruiting inflam-
matory cells to the airway. Interleukin
(IL)-6, for example, secreted in response to
pollutants, particles or allergens, recruits
monocytes. Additional chemoattractive
substances released by epithelial cells direct
infiltration of B and T lymphocytes,
neutrophils, basophils, and eosinophils (5).
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Infiltrating inflammatory cells, together
with resident and infiltrating alveolar
macrophages, mount specific defenses
against inhaled deleterious substances. For
example, antibody production against
incoming allergens occurs as IL-6 promotes
activation ofinfiltrating B and T lympho-
cytes (6). Accumulating neutrophils and
macrophages generate and release large
amounts of ROS/RNS in a respiratory
burst designed to combat inhaled infec-
tious agents such as bacteria and viruses
(7). ROS/RNS, produced either during
this respiratory burst or inhaled into the
airway, elicit a variety of responses from
airway epithelium. Exogenous ROS have
been shown to cause an increase in mucin
secretion (8), as well as to stimulate
enzymes such as phospholipase C that
serve as important roles in signal transduc-
tion cascades within cells (9). Inhaled oxi-
dants such as ozone induce DNA-binding
activity of transcription factors such as
nuclear factor kappa B (NF-icB), nuclear
factor IL-6 (NFIL-6), and activator protein
1 (AP-1) in type II-like epithelial cells
(A549), demonstrating a potential role for
epithelial cells in the oxidant-induced
expression ofcytokines such as IL-8 (10).
The epithelium can also produce
ROS/RNS directly. Bronchial and tracheal
epithelial cells release H202 in response to
inflammatory stimuli (11,12). Nitric
oxide ('NO) can be produced in response
to various cytokines or endotoxin by an
inducible form of nitric oxide synthase
(iNOS) localized to the airway epithe-
lium (13-16). Together with released
ROS/RNS, airway epithelial cells also
produce intracellular ROS/RNS that
serve as signaling molecules, provoking
changes in mucin secretion and integrin
expression (8,9,17,18).
The defensive physiologic reactions
occurring within the airway in response to
inhaled deleterious substances appear to play
a role in inflammatory airway and lung dis-
eases. Although the exact mechanisms that
turn effective defense strategies into those
that perpetuate inflammatory respiratory
diseases such as allergic and nonallergic
asthma, chronic bronchitis, chronic obs-
tructive pulmonary disease (COPD), cystic
fibrosis, and acute respiratory distress
syndrome (ARDS) are poorly understood, it
is likely that changes in expression of
inflammation-associated genes, and ulti-
mately, expression oftheir products, play a
role in this process. ROS/RNS appear to
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function at pivotal points within signal
transduction pathways controlling expres-
sion ofproinflammatory proteins.
Interaction ofOxidants
and Cells
Sources ofOxidants
Exogenous Sources ofROSIRNS. Airway
epithelial cells are continuously exposed to
exogenous and endogenous sources of
ROS/RNS. Environmental pollutants are a
major source ofexogenous oxidative species.
Such pollutants include particles and fibers
such as industrially derived ground silica
and asbestos that may themselves contain
free radicals capable ofreacting directly with
lipids and proteins in the airway cells and
fluids (19,20). Particles such as residual oil
fly ash and ambient air dusts may contain
ionizable concentrations oftransition metals
capable ofgenerating ROS in airways (21).
Inhaled gaseous pollutants such as ozone,
nitrogen dioxide, automobile exhaust, and
cigarette smoke also contain numerous oxi-
dants, further adding to the oxidant burden
in the airway upon inhalation (22).
Although particles themselves may
contain free radicals, additional reactive
species can be generated after phagocytosis
ofcertain particles by macrophages present
within the airway. For example, ground
silica activates a greater respiratory burst in
macrophages than does aged silica (19).
Various transition metal-containing dusts
cause release ofsuperoxide anion radical
and H202 from resident macrophages
after in vivoexposure (23).
Therapies that increase oxygenation of
the body's organ systems during congestive
lung diseases such as cystic fibrosis, COPD,
and ARDS are also a source ofexogenous
ROS/RNS (24). Based on observed abnor-
mal changes, this prolonged exposure to
high oxygen concentrations combined with
positive pressure mechanical ventilation can
cause acute lung injury (25). Although no
prospective randomized clinical trials have
been conducted on the use of 'NO as a
therapeutic agent for treatment ofconges-
tive lung disease, its use suggests some posi-
tive benefits such as increased oxygenation
and reduced pulmonary arterial pressure.
Use of NO to decrease the oxygen require-
ment may be only ofshort-term benefit,
however, as the potential for 'NO toxicity
during treatment is very real. Specifically,
*NO is capable of further reaction with
oxygen and superoxide anion radical in the
ventilated airway to form toxic products
such as peroxynitrite (24).
Probably the greatest source ofreactive
species within the airway, however, derives
from endogenous and infiltrating inflam-
matory cells present after exposure to
exogenous pollutants, antigens, bacteria, or
viruses. The airways of asthmatics also
show increased levels ofinflammatory cells
such as monocytes that can be a source of
reactive species (26). Reactive species in
affected airways result mainly from the res-
piratory burst ofstimulated macrophages
and from stimulated polymorphonuclear
leukocytes (neutrophils) (7).
Endogenous Sources ofROSIRNS.
Endogenous reactive species can also be
generated within the airway epithelial cells
in response to proinflammatory cytokines
such as tumor necrosis factor alpha (TNF-
a) (27,28). This relationship is evidenced
by the conversion ofcellular glutathione to
its oxidized form, presumably as a protec-
tion against increased intracellular oxi-
dants, following exposure of human
epithelial type II cells (A549) to TNF-a
(29). At least some ofthe reactive species
generated in response to TNF-a appear to
be side products derived from electron
transport reactions taking place in mito-
chondria ofstimulated cells (28,30). TNF-a
can also upregulate gene expression and
activity ofxanthine oxidase, a very abun-
dant enzyme in epithelial cells, which can
lead to generation ofsuperoxide anion rad-
ical and H202 from oxygen encountered
within airways. The presence ofadditional
cytokines such as interferon-y, IL-1, and
IL-6 causes additive effects on xanthine
oxidase upregulation, adding further to the
oxidant burden within epithelial cells
(31,32). Additional ROS are also formed
in airway epithelium through the action of
cell-associated oxidative enzymes such as
NADPH oxidase and cyclooxygenase (33).
*NO, a highly reactive nitrogen species, is
generated in response to inflammatory
cytokines by the iNOS localized to airway
epithelium (14).
CellularDefensesagainstOxidants
As exposure to potentially damaging
oxidative stress is unavoidable in airway
epithelial cells, these cells use numerous
antioxidant defenses evolved by cells in
aerobic organisms to counter the cytotoxic
effects of ROS/RNS. These mechanisms
include both enzymatic and nonenzymatic
defenses. The most important antioxidant
enzymes within airway epithelial cells
include catalase (CAT), superoxide dis-
mutase (SOD), and glutathione-cycle
enzymes such as glutathione peroxidase
(GSHPx). SOD dismutes superoxide to
H202, which can then be processed further
by CAT or the glutathione cycle. The
CuZn form of SOD is constitutively
expressed in the cytosol and nucleus of
epithelial cells, whereas the inducible man-
ganese form (MnSOD) is located in the
mitochondria (34). Evidence suggests
MnSOD can be upregulated by ROS or
cytokines such as TNF-a, IL-1 and IL-6,
or inflammatory minerals (35-40). This
may provide epithelial cells with protection
in inflammatory situations where increases
in reactive species are likely (41).
The ability of CAT and GSHPx to
consume H202 in airway epithelial cells
has been suggested using inhibitory exper-
iments. Although inhibition of GSHPx
potentiates the damage observed in
epithelial cells after exposure to exogenous
H202, only inhibition of CAT signifi-
cantly inhibits the ability of tracheal and
alveolar epithelial cells to consume H202
(42-44). The glutathione oxidation-
reduction cycle aids in reduction ofintra-
cellular hydroperoxides and plays an
important role in degrading lipid perox-
ides and products of lipoxygenase-
catalyzed reactions (45). The prevalence
of these enzymes in airway epithelial cells
likely plays a role in maintaining a healthy
airway. Glutathione is particularly abun-
dant in lung epithelial lining fluids at
concentrations approximately 100-fold
greater than those observed in plasma
(46). Greater concentrations oftotal glu-
tathione are observed in bronchial and
alveolar fluid from asthmatics compared
to that in normal control subjects (47).
These findings, coupled with an observed
reduction in GSHPx levels in asthmatic
adults and children (48), suggest ROS are
inappropriately defended against in
inflammatory respiratory diseases, leading
to increased morbidity.
Nonenzymatic antioxidants, including
vitamins C and E, P-carotene, uric acid,
and thiols, also function to protect airway
epithelial cells from oxidative stress.
Carotenoids and vitamin C act to quench
radicals in nonlipid cellular compart-
ments. Oxidation oflipids is countered by
vitamin E acting to stop the chain reac-
tion involved in lipid peroxidation, and
by uric acid (49). Uric acid also protects
against oxidative damage ofproteins and
nucleobases by directly scavenging
hydroxyl radical, singlet oxygen, hypo-
chlorous acid, oxoheme oxidants, and
hydroperoxyl radicals. Iron, which could
also contribute to the production of
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intracellular oxidant species via the
Fenton reaction, is immobilized by uric
acid, a potent iron chelator (50,51). Protein
sulfhydryls appear to be protected against
irreversible oxidation by the reversible
process of S-thiolation-dethiolation. In
these reactions, sulfhydryl groups on pro-
teins become covalently bound to glu-
tathione, y-glutamylcysteine, or cysteine
following a large oxidative insult such as
the monocyte respiratory burst. The
glutathione-thioredoxin reductase systems
are implicated in the dethiolation process
(52). Finally, some proteins produced in
response to cellular stress may also play a
role in protecting the cell from damage by
oxidative species. One such protein is
heme oxygenase 1, which catalyzes the
rate-limiting step in the conversion of
heme to bilirubin. Thus, with the produc-
tion of additional bilirubin, an efficient
free radical scavenger, the intracellular
oxidant burden can be decreased (53,54).
The airway epithelium is also protected
from ROS by the overlying mucus. Mucus,
which has antioxidant capabilities, may act
similarly to mannitol and glucose in scav-
enging hydroxyl radical and H202 because
ofits manysugar moieties (55-57). In cul-
tured guinea pig epithelial cells (GPTE),
removal ofthe apical mucus layer reduces
the efficiency of H202 scavenging (58).
Thus, in diseases such as cystic fibrosis,
asthma, or ARDS, in which the epithelial
layer is injured via denuding, fibrosis, pres-
sure injury, or increased mucus viscosity,
further injury may occur from decreased
ability ofthe mucus to serve as an antioxi-
dant. Exposure to inhaled air pollutants
may also injure the airway as mucus pro-
duction is altered and epithelial cells are
destroyed, resulting in a similar loss of
antioxidant function (59,60).
Mechanisms to Alter Gene
Expression in Response
to Oxidants
The airway epithelium responds function-
ally to exposure to ROS/RNS whether
from exogenous or endogenous sources.
Functional responses from epithelial cells
can include increases in secretion ofmucus,
surface expression ofadhesion molecules,
and release of cytokines. Most of these
changes are regulated by changes in expres-
sion ofgenes within the cells. Thus, it is
important to understand the numerous
molecular mechanisms by which oxidant
species can alter gene expression. In this
way, it may be possible to understand how
functional reactions to oxidative species can
at times serve to prevent disease, and at
other times exacerbate airway inflammation.
Oxidant-SensitiveTranscription
Factors
The redox state ofa cell may be altered by
encounters with exogenous ROS/RNS or
inflammatory mediators such as TNF-a.
For cellular function to be modulated,
the cell must respond to these shifts in
oxidation-reduction equilibria, or to pro-
duction of new reactive signaling mole-
cules, through modulation of regulatory
proteins that have the potential to initiate
gene transcription (33,61), as illustrated
in Figure 1. Two transcription factors
regulated by the redox state ofthe cell are
NF-KB and AP-1 (62). Nuclear transloca-
tion and subsequent binding to DNA of
the NF-KB complex occurs in response to
H202, hypochlorous acid, and multiple
cytokines (63,64). Once in the nucleus,
these dimers bind a consensus sequence
found in the promoter region of many
genes, including those coding for
cytokines such as IL-6, IL-8, IL-1, and
Macrophage
0
TNF-a\
TNF-a. Activation of NF-icB has been
demonstrated in inflammatory cells from
patients with airway diseases, suggesting
an in vivo role for this complex in regulat-
ing expression of these cytokine genes
(65). The activation ofAP-1 appears to
oppose that of NF-KB. For example,
TNF-a-induced activation ofAP-1 can be
increased by exposure to antioxidants
such as pyrrolidine dithiocarbamate
(PDTC) (66).
ROS appear to regulate NF-KB function
via effects on I-KB, a family of inhibitory
subunits regulated by phosphorylation that
controls the activity and nuclear transloca-
tion ofNF-iKB. Specifically, intracellular
ROS appear to play a key role in regulating
phosphorylation ofI-KB. For example, cells
overexpressing GSHPx exhibit decreased
translocation of NF-icB and decreased
phosphorylation of I-KB in response to
oxidative stress or TNF-a exposure. A
correlation also exists between the rise in
ROS levels in TNF-ax-stimulated cells and
the degradation ofI-KB, which presumably
occurs because of the increase in its
Inhaled substances
ROS/RNS
,vr
Neutrophil
Figure 1. Scheme illustrating the role reactive oxygen and nitrogen species may play in regulating the expression
of inflammation-associated genes in airway epithelial cells. ROS/RNS serve as both exogenous stimuli and intra-
cellular signaling molecules in airway epithelial cells. A variety of stimuli (i.e., reactive species, cytokines) elicit
the generation of intracellular ROS/RNS by enzymes such as those shown in the cytoplasm at left. It is the balance
between the reactive species generated bythese enzymes and their reaction with antioxidants such as those illus-
trated at right that alters the redox state ofthe cell. As the redox state is altered, a number oftranscription factors
including NF-icB, AP-1, and NFIL-6 respond by binding to the promoter regions of inflammation-associated genes,
causing theirexpression.
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phosphorylated state (67). The upregulated
phosphorylation ofI-KB results in release of
NF-iKB from the NF-B:I-iKB inhibitory
complex, allowing its nudear translocation
and subsequent transcriptional upregula-
tion ofvarious inflammation-associated
genes (68).
OxidntEffects onSignal
TranductionPathways
Although some of the mechanisms that
directly alter the function of oxidant-
sensitive transcription factors are known,
far less is understood about how the signal
transduction pathways that trigger these
mechanisms are affected by oxidative
stress. Lipid peroxidation is a known cause
ofcellular injury resulting from oxidative
stress. Specific ROS trigger activation of
membrane-associated enzymes that likely
play a role in signaling pathways affecting
such injury. For example, t-butyl hydro-
peroxide activates phospholipase A2,
ultimately stimulating cyclooxygenase
metabolism (69). Exposure to ozone
results in release of arachidonic acid,
eicosanoids, and platelet-activating factor
from a variety of pulmonary cell types
(70,71). Preliminary studies from our lab-
oratory suggest protein kinase C (PKC)
translocation and activation is stimulated
by ROS produced from purine+xanthine
oxidase in GPTE and BEAS-2B cells.
Other enzymes associated with
intracellular signaling pathways may also
be redox sensitive. At least two members
of the src family of protein tyrosine
kinases have been activated by H202. In
addition, the protein tyrosine kinase syk is
responsive to treatment of B cells with
H202 (72). Protein-tyrosine phosphatases
have reactive cysteine residues in their
active sites that may make these enzymes
oxidant sensitive (73). Studies using
inhibitors have also suggested that IL-8
gene expression in response to asbestos
exposure may be governed by redox-
induced changes leading to phosphor-
ylation events, mediated by tyrosine
kinases. In addition, this signaling path-
way may involve PKC. Ultimately, the
phosphorylation events set in motion by
this redox-sensitive pathway appear to
activate nudear proteins that recognize the
NF-cB/NFIL-6 sites ofthe IL-8 promoter,
contributing to IL-8 gene expression (74).
Other steps in intracellular signaling
pathways may also be oxidant regulated.
For example, hydroperoxides increase the
concentration of intracellular calcium
(75,76). Some studies suggest that H202
treatment induces inositol-1,4,5-triphos-
phate (IP3) production, which allows IP3
to bind to receptors on the endoplasmic
reticulum and provoke release ofintracellu-
larly stored calcium (72). It may be this
increase in calcium that then stimulates
phospholipase activity resulting in prote-
olytic events that have direct effects on the
activation of transcription factors such as
NF-icB (61,76).
Role of ROS/RNS in
Inflammatory Respiratory
Disease
ExpressionofInflammaion-
AssodatedGenes
A number ofgenes and their products are
upregulated in patients with respiratory
diseases such as asthma, chronic bronchitis,
COPD, cystic fibrosis, and ARDS. IL-6
levels are increased in bronchoalveolar
lavage (BAL) fluid taken from asthmatics
compared to levels in BAL from control
subjects (26). Epithelial cells from asthmat-
ics also show a corresponding increase in
IL-6 mRNA (77). IL-8 levels are increased
in sputum from COPD patients compared
with those in sputum of control subjects
(nonsmokers, cigarette smokers without
disease, or asthmatic patients) (78). Asimi-
lar increase in the expression ofintercellu-
lar adhesion molecule 1 (ICAM-1) has
been observed in asthma, chronic bronchi-
tis, ARDS, and COPD (79,80). ICAM-1
promotes immunologic and inflammatory
reactions such as leukocyte diapedesis
within the lung. Because ICAM-1 appears
to be important for the adhesion ofinflam-
matory cells in the airway, its overexpres-
sion may allow more inflammatory cells to
remain in the airway for long periods of
time. This persistence of inflammatory
cells in the airway likely plays a role in
exacerbating the injury and inflammation
observed in respiratory diseases. For exam-
ple, the presence ofneutrophils results in
release ofsubstantial amounts ofROS and
destructive enzymes such as elastase (7). In
ARDS, such activated neutrophils also
release cytokines such as TNF-a, IL-6, and
IL-8, which can further enhance the
inflammatoryresponse (81-83).
Reulation ofICAM-1 Expression
Distinct cis-regulatory elements within the
ICAM-1 promoter thatrespond to oxidants,
as well as TNF-a, have been functionally
identified using endothelial cells (84).
Recent experiments in our laboratory
demonstrate that ICAM-1 is basally
expressed on the surface ofnormal human
bronchial epithelial (NHBE) cells grown
in primary cultures. This basal expression
can be stimulated by TNF-a at the levels
ofmRNA and surface expression. Studies
utilizing Northern blot analysis demon-
strated that 1 hr of TNF-a exposure
increased ICAM-1 steady-state mRNA
above control levels. This TNF-a-stimu-
lated increase in ICAM-1 mRNA can be
inhibited by actinomycin D, which inhibits
RNA polymerase II. Investigations into
effects ofthe antioxidants dimethylthiourea
(DMTU) and PDTC on TNF-a-induced
ICAM-1 expression reveal the ability of
these antioxidants to inhibit ICAM-1
expression at the surface and mRNA level
(85). These data suggest a role for intracel-
lular ROS/RNS in the intracellular path-
way regulating ICAM-1 gene expression in
airwayepithelium.
Because TNF-a-induced ICAM-1
expression appears to be regulated mainly at
the level oftranscription in NHBE cells, it
is possible that intracellular reactive species
are acting to alter activation ofoxidant-sen-
sitive transcription factors such as NF-cB.
One consensus NF-iKB-binding site located
in the human ICAM-1 promoter has been
functionally identified as important for
expression ofICAM-1 in response to TNF-
a in endothelial cells. Using this NF-icB
binding site in an electrophoretic mobility
shift assay (EMSA), we have demonstrated
that protein in nuclear extracts stimulated
with TNF-a binds to this site in vitro.
Examination ofthe bound complex with
appropriate antibodies indicates binding of
NF-iKB proteinsubunits.
ReglationofIL-6Expression
An increase in IL-6 also is observed in a
variety ofrespiratory diseases. TNF-a and
reactive species that are released from
stimulated infiltrating neutrophils and
macrophages during disease increase pro-
duction ofIL-6 in a number ofcell types,
including fibroblasts. Little, however, is
known about expression of IL-6 in
response to these inflammation-associated
agents in airway epithelium. We have
recently observed an increase in secreted
IL-6 in response to treatment of NHBE
cells with oxidants, mainly superoxide
anion radicals generated by purine + xan-
thine oxidase (PXO), or with TNF-a.
Interestingly, a time course of mRNA
increase during these treatments reveals
that the IL-6 steady-state message rapidly
increases in response to PXO (in 30 min)
and returns to near control levels by 1 hr.
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In contrast, treatment ofNHBE cells with
TNF-a results in an increase in steady-
state message byl hr that remains elevated
even up to 8 hr posttreatment (86). Thus,
it appears that these two types ofstimuli
may exert their effects on IL-6 expression
via different molecular mechanisms or
signal transduction pathways.
The highly cell-permeable oxidant
scavenger DMTU can block the increase
in secreted IL-6 observed following expo-
sure of cells to PXO or TNF-a (86).
These data suggest that intracellular reac-
tive species play a role in signaling an
increase in IL-6 expression in response to
exogenous oxidant stress or TNF-a.
Species that may be involved in this sig-
naling include hydroxyl radical, H202,
hypochlorous acid, or peroxynitrite, as all
ofthese species reactwith DMTU (87).
Efforts are currently under way in our
laboratory to determine the level at which
IL-6 gene expression is regulated in
response to PXO or TNF-a. Work to
date suggests that newly synthesized pro-
teins are not needed for IL-6 expression in
response to PXO, as cycloheximide can-
not block the PXO-induced increase in
the IL-6 mRNA. In contrast, when
NHBE cells are incubated with actino-
mycin D plus PXO, the level ofsteady-
state mRNA falls below that observed in
untreated control cells (86). Although
this suggests at least some role for tran-
scription in regulation of IL-6 gene
expression in response to oxidative stress,
it is also consistent with an mRNA stability
component to this regulation. A modu-
lation in mRNA stability would help
account for the rapid rise and fall observed
in the steady-state IL-6 mRNA in response
to PXO.
As there appears to be some component
of transcriptional regulation to IL-6
expression, we have begun to examine the
ability ofnuclear proteins to bind to sites
present in the IL-6 promoter using
EMSAs. Nuclear extracts from cells
exposed to PXO or TNF-a were used in
shift assays with either the NF-iKB or
NFIL-6 site found in the IL-6 promoter.
Interestingly, extracts treated with PXO or
TNF-a had different patterns ofbinding
to these sequences. TNF-ac-treated extracts
exhibited a greater amount ofbinding to
the NF-iKB site when compared with bind-
ing of proteins from control extracts.
However, no changes in the ability ofthe
treated extracts to bind the NFIL-6 site
were observed. In contrast, nuclear extracts
from PXO-treated cells caused an increase
in binding to the NFIL-6 site but not the
NF-cB site (86). These data suggest differ-
ent modes oftranscriptional regulation of
IL-6 gene expression in response to PXO
or TNF-a. In addition, they suggest that
although NFIL-6 has not been tradition-
ally considered an oxidant-sensitive
transcription factor, it does appear to
respond to exogenous oxidant stress. It
now remains to determine whether these
transcription factor sites play a role in
differential expression ofIL-6 in response
to these two stimuli in vivo.
Conclusions
ROS/RNS can play a variety of roles in
signaling pathways that lead to changes in
expression of proteins important to the
development ofinflammatory airway and
lung disease. ROS/RNS can serve as direct
injury-causing agents, as exogenous stimuli
that cause production of inflammatory
mediators from epithelial cells, as intracel-
lular signaling molecules, and as modula-
tors ofthe redox state in epithelial cells. In
these capacities, ROS/RNS appear to
function as modulators ofthe expression
of epithelial genes whose products are
proinflammatory or act in other ways to
prolong the presence ofinflammatory cells
in diseased airways. Intracellular ROS/RNS
can serve as signaling molecules in signal
transduction cascades that ultimately trig-
ger changes in expression of epithelial
genes. As the redox state within epithelial
cells changes during the production of
such reactive species, transcription factors
become activated. In this manner, the
transcriptionally controlled expression of
gene products such as IL-6, ICAM-1, and
mucin is modulated during inflammatory
airway disease or inhaled environmental
insult. Whether an effective defensive
mechanism or a pathologic state results in
the airway likely depends on the precise
regulation ofthe expression ofsuch genes
via mechanisms involving ROS/RNS.
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